Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saredutant + Paroxetine in MDD
NCT00629551Phase 3Completed
- Sponsor
- Sanofi
- Start
- Feb 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of saredutant in major depressive disorder (MDD), sponsored by Sanofi. Started Feb 2008; status: completed.
02
Drugs
saredutant
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00629551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00629551.